Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 329

1.

Quantification of dynamic 11C-Phenytoin PET studies.

Mansor MS, Boellaard R, Froklage FE, Bakker ED, Yaqub M, Voskuyl RA, Schwarte LA, Verbeek J, Windhorst AD, Lammertsma AA.

J Nucl Med. 2015 Jul 1. pii: jnumed.115.158055. [Epub ahead of print]

PMID:
26135114
2.

Knee joint replacement and individual susceptibility for progression of knee osteoarthritis and tibial cartilage volume loss: not only genes run in the family.

Kuijer PP, Kievit AJ, Verbeek JH, Burdorf A, Frings-Dresen MH.

Osteoarthritis Cartilage. 2015 Jun 4. pii: S1063-4584(15)01189-9. doi: 10.1016/j.joca.2015.02.1000. [Epub ahead of print] No abstract available.

PMID:
26050869
3.

A search strategy to identify studies on the prognosis of work disability: a diagnostic test framework.

Kok R, Verbeek JA, Faber B, van Dijk FJ, Hoving JL.

BMJ Open. 2015 May 19;5(5):e006315. doi: 10.1136/bmjopen-2014-006315.

4.

A questionnaire to measure medical students' attitudes towards occupational medicine.

Smits PB, Verbeek JH.

Occup Med (Lond). 2015 Jul;65(5):402-4. doi: 10.1093/occmed/kqv055. Epub 2015 May 11.

PMID:
25964510
5.

Topical antifungals for seborrhoeic dermatitis.

Okokon EO, Verbeek JH, Ruotsalainen JH, Ojo OA, Bakhoya VN.

Cochrane Database Syst Rev. 2015 May 2;5:CD008138. doi: 10.1002/14651858.CD008138.pub3.

PMID:
25933684
6.

Topical antifungals for seborrhoeic dermatitis.

Okokon EO, Verbeek JH, Ruotsalainen JH, Ojo OA, Bakhoya VN.

Cochrane Database Syst Rev. 2015 Apr 28;4:CD008138. doi: 10.1002/14651858.CD008138.pub2.

7.

Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivo.

Roghanian A, Teige I, Mårtensson L, Cox KL, Kovacek M, Ljungars A, Mattson J, Sundberg A, Vaughan AT, Shah V, Smyth NR, Sheth B, Chan HT, Li ZC, Williams EL, Manfredi G, Oldham RJ, Mockridge CI, James SA, Dahal LN, Hussain K, Nilsson B, Verbeek JS, Juliusson G, Hansson M, Jerkeman M, Johnson PW, Davies A, Beers SA, Glennie MJ, Frendéus B, Cragg MS.

Cancer Cell. 2015 Apr 13;27(4):473-88. doi: 10.1016/j.ccell.2015.03.005.

PMID:
25873171
8.

Preventing occupational stress in healthcare workers.

Ruotsalainen JH, Verbeek JH, Mariné A, Serra C.

Cochrane Database Syst Rev. 2015 Apr 7;4:CD002892. [Epub ahead of print]

PMID:
25847433
9.

Immune antibodies and helminth products drive CXCR2-dependent macrophage-myofibroblast crosstalk to promote intestinal repair.

Esser-von Bieren J, Volpe B, Sutherland DB, Bürgi J, Verbeek JS, Marsland BJ, Urban JF Jr, Harris NL.

PLoS Pathog. 2015 Mar 25;11(3):e1004778. doi: 10.1371/journal.ppat.1004778. eCollection 2015 Mar.

10.

The long pentraxin PTX3 promotes fibrocyte differentiation.

Pilling D, Cox N, Vakil V, Verbeek JS, Gomer RH.

PLoS One. 2015 Mar 16;10(3):e0119709. doi: 10.1371/journal.pone.0119709. eCollection 2015.

11.

Pharmacological interventions for sleepiness and sleep disturbances caused by shift work.

Liira J, Verbeek J, Ruotsalainen J.

JAMA. 2015 Mar 3;313(9):961-2. doi: 10.1001/jama.2014.18422.

PMID:
25734738
12.

Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract symptoms, infections and asthma.

Sauni R, Verbeek JH, Uitti J, Jauhiainen M, Kreiss K, Sigsgaard T.

Cochrane Database Syst Rev. 2015 Feb 25;2:CD007897. doi: 10.1002/14651858.CD007897.pub3. Review.

PMID:
25715323
13.

Topical anti-inflammatory agents for seborrheic dermatitis of the face or scalp: summary of a Cochrane Review.

Kastarinen H, Okokon EO, Verbeek JH.

JAMA Dermatol. 2015 Feb;151(2):221-2. doi: 10.1001/jamadermatol.2014.3186.

PMID:
25629391
14.

Pharmacological interventions for sleepiness and sleep disturbances caused by shift work.

Liira J, Verbeek JH, Costa G, Driscoll TR, Sallinen M, Isotalo LK, Ruotsalainen JH.

Sao Paulo Med J. 2015 Feb;133(1):67. doi: 10.1590/1516-3180.20151331T1. Epub 2015 Jan 1.

15.

CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis.

Karpus ON, Kiener HP, Niederreiter B, Yilmaz-Elis AS, van der Kaa J, Ramaglia V, Arens R, Smolen JS, Botto M, Tak PP, Verbeek JS, Hamann J.

Arthritis Res Ther. 2015 Jan 17;17(1):6. doi: 10.1186/s13075-015-0518-4.

16.

Antibody-mediated trapping of helminth larvae requires CD11b and Fcγ receptor I.

Esser-von Bieren J, Volpe B, Kulagin M, Sutherland DB, Guiet R, Seitz A, Marsland BJ, Verbeek JS, Harris NL.

J Immunol. 2015 Feb 1;194(3):1154-63. doi: 10.4049/jimmunol.1401645. Epub 2014 Dec 29.

17.

Conformation of the human immunoglobulin G2 hinge imparts superagonistic properties to immunostimulatory anticancer antibodies.

White AL, Chan HT, French RR, Willoughby J, Mockridge CI, Roghanian A, Penfold CA, Booth SG, Dodhy A, Polak ME, Potter EA, Ardern-Jones MR, Verbeek JS, Johnson PW, Al-Shamkhani A, Cragg MS, Beers SA, Glennie MJ.

Cancer Cell. 2015 Jan 12;27(1):138-48. doi: 10.1016/j.ccell.2014.11.001. Epub 2014 Dec 11.

18.

Preventing occupational stress in healthcare workers.

Ruotsalainen JH, Verbeek JH, Mariné A, Serra C.

Cochrane Database Syst Rev. 2014 Dec 8;12:CD002892. doi: 10.1002/14651858.CD002892.pub4. Review.

PMID:
25482522
19.

Interventions to improve return to work in depressed people.

Nieuwenhuijsen K, Faber B, Verbeek JH, Neumeyer-Gromen A, Hees HL, Verhoeven AC, van der Feltz-Cornelis CM, Bültmann U.

Cochrane Database Syst Rev. 2014 Dec 3;12:CD006237. doi: 10.1002/14651858.CD006237.pub3. Review.

PMID:
25470301
20.

Comments on TTS as a predictor of noise-induced hearing loss.

Verbeek JH.

Occup Environ Med. 2015 Feb;72(2):160. doi: 10.1136/oemed-2014-102555. Epub 2014 Nov 18. No abstract available.

PMID:
25406474
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk